WallStreetZen

NYSE: ABT
Abbott Laboratories Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

ABT past earnings growth

How has ABT's earnings growth performed historically?
Company
104%
Industry
121.16%
Market
103.11%
ABT's earnings have grown faster (18.62% per year) than the US Medical Devices industry average (14.08%)
Performance
ABT's earnings have grown slower (18.62% per year) than the US market average (30.14%)
Performance
ABT's earnings growth is accelerating - its growth over the last year (104%) is above its 5-year compound annual rate (18.62%)
Performance

ABT past revenue growth

How has ABT's revenue growth performed historically?
Company
27.95%
Industry
24.76%
Market
45.4%
ABT's revenue has grown slower (14.37% per year) than the US Medical Devices industry average (18.45%)
Performance
ABT's revenue has grown slower (14.37% per year) than the US market average (19.13%)
Performance
ABT's revenue growth is accelerating - its growth over the last year (27.95%) is above its 5-year compound annual rate (14.37%)
Performance

ABT earnings and revenue history

Current Revenue
$40.2B
Current Earnings
$6.4B
Current Profit Margin
15.8%
ABT's has not demonstrated consistent long-term earnings growth over the past 10 years (8.18%)
Performance

ABT Return on equity

Current Company
19.3%
Current Industry
33.1%
Current Market
32.9%
ABT's Return on Equity (19.3%) shows a company that is not efficient at transforming shareholder equity into returns
Performance

ABT Return on assets

Current Company
8.9%
Current Industry
5.8%
Current Market
7.7%
ABT is generating higher Return on Assets (8.9%) than the US Medical Devices industry average (6.28%)
Performance

ABT Return on capital employed

Current Company
12.77%
Current Industry
9.2%
ABT has gotten more efficient at generating Return on Capital (12.77%) compared to 3 years ago (5.74%)
Performance

ABT earnings dates

Next earnings date
Oct 19, 2021

Abbott Laboratories Earnings & Revenue FAQ

What were ABT's earnings last quarter?

On Invalid Date, Abbott Laboratories (NYSE: ABT) reported Q2 2021 earnings per share (EPS) of $0.67, up 123.33% year over year. Total Abbott Laboratories earnings for the quarter were $1.19 billion. In the same quarter last year, Abbott Laboratories's earnings per share (EPS) was $0.30.

What was ABT's earnings growth in the past year?

As of Q3 2021, Abbott Laboratories's earnings has grown 104% year over year. This is 17.16 percentage points lower than the US Medical Devices industry earnings growth rate of 121.16%. Abbott Laboratories's earnings in the past year totalled $6.38 billion.

What is ABT's earnings date?

Abbott Laboratories's earnings date is Invalid Date. Add ABT to your watchlist to be reminded of ABT's next earnings announcement.

What was ABT's revenue last quarter?

On Invalid Date, Abbott Laboratories (NYSE: ABT) reported Q2 2021 revenue of $10.22 billion up 39.51% year over year. In the same quarter last year, Abbott Laboratories's revenue was $7.33 billion.

What was ABT's revenue growth in the past year?

As of Q3 2021, Abbott Laboratories's revenue has grown 27.95% year over year. This is 3.19 percentage points higher than the US Medical Devices industry revenue growth rate of 24.76%. Abbott Laboratories's revenue in the past year totalled $40.23 billion.
©2021 WallStreetZen
Company
AboutBlogPlansPrivacy PolicyTerms of ServiceContact
Stocks
Stock ScreenerStock ForecastHighest Earnings StocksBest Dividend Paying StocksStatisticsTrending Stocks
Analysts
Top Performing Analysts
Social
TwitterYouTube
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.